The debate around tax inversions obscures the benefits on hand from a potential Pfizer-Allergan combination.
WSJ.com: Heard on the Street, Wall Street Journal: Markets: Heard on the Street
Fri, 11/20/2015 - 12:52pm
The debate around tax inversions obscures the benefits on hand from a potential Pfizer-Allergan combination.